TNF-α has been shown to upregulate sclerostin expression in MLO-Y4 cells [27]; consistent with this finding, the use of a TNF-α antagonist was able to diminish RANKL and sclerostin expression in the osteocytes of diabetic rats with periodontitis [28]. Here, TNF is linked to periodontitis.